A Phase 2 Feasibility Trial of the Oral Direct Thrombin Inhibitor AZD0837 in the Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation, Who Are Unable or Unwilling to Take Warfarin Therapy

Gregory Y. Lip; Lars H. Rasmussen; Sol-Britt Olsson; Sofia Zetterstrand; Christina Stahre; Anders Bylock; Maria Aunes-Jansson; Karin Wahlander

A Phase 2 Feasibility Trial of the Oral Direct Thrombin Inhibitor AZD0837 in the Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation, Who Are Unable or Unwilling to Take Warfarin Therapy

Gregory Y. Lip, Lars H. Rasmussen, Sol-Britt Olsson, Sofia Zetterstrand, Christina Stahre, Anders Bylock, Maria Aunes-Jansson, Karin Wahlander

Breastcancer-genetics

Research output: Contribution to journal › Published meeting abstract › peer-review

Original language	English
Pages (from-to)	S1129-S1129
Journal	Circulation
Volume	120
Issue number	18
Publication status	Published - 2009
Event	82nd Scientific Session of the American-Heart-Association - Orlando, FL, United States Duration: 2009 Nov 14 → 2009 Nov 18

Subject classification (UKÄ)

Cardiac and Cardiovascular Systems

Cite this

Lip, G. Y., Rasmussen, L. H., Olsson, S.-B., Zetterstrand, S., Stahre, C., Bylock, A., Aunes-Jansson, M., & Wahlander, K. (2009). A Phase 2 Feasibility Trial of the Oral Direct Thrombin Inhibitor AZD0837 in the Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation, Who Are Unable or Unwilling to Take Warfarin Therapy. Circulation, 120(18), S1129-S1129.

@article{756a3709f2bc4bd197bc89643590a5ae,

title = "A Phase 2 Feasibility Trial of the Oral Direct Thrombin Inhibitor AZD0837 in the Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation, Who Are Unable or Unwilling to Take Warfarin Therapy",

author = "Lip, {Gregory Y.} and Rasmussen, {Lars H.} and Sol-Britt Olsson and Sofia Zetterstrand and Christina Stahre and Anders Bylock and Maria Aunes-Jansson and Karin Wahlander",

year = "2009",

language = "English",

volume = "120",

pages = "S1129--S1129",

journal = "Circulation",

issn = "1524-4539",

publisher = "Lippincott Williams & Wilkins",

number = "18",

note = "82nd Scientific Session of the American-Heart-Association ; Conference date: 14-11-2009 Through 18-11-2009",

}

Lip, GY, Rasmussen, LH, Olsson, S-B, Zetterstrand, S, Stahre, C, Bylock, A, Aunes-Jansson, M & Wahlander, K 2009, 'A Phase 2 Feasibility Trial of the Oral Direct Thrombin Inhibitor AZD0837 in the Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation, Who Are Unable or Unwilling to Take Warfarin Therapy', Circulation, vol. 120, no. 18, pp. S1129-S1129.

A Phase 2 Feasibility Trial of the Oral Direct Thrombin Inhibitor AZD0837 in the Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation, Who Are Unable or Unwilling to Take Warfarin Therapy. / Lip, Gregory Y.; Rasmussen, Lars H.; Olsson, Sol-Britt et al.
In: Circulation, Vol. 120, No. 18, 2009, p. S1129-S1129.

Research output: Contribution to journal › Published meeting abstract › peer-review

TY - JOUR

T1 - A Phase 2 Feasibility Trial of the Oral Direct Thrombin Inhibitor AZD0837 in the Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation, Who Are Unable or Unwilling to Take Warfarin Therapy

AU - Lip, Gregory Y.

AU - Rasmussen, Lars H.

AU - Olsson, Sol-Britt

AU - Zetterstrand, Sofia

AU - Stahre, Christina

AU - Bylock, Anders

AU - Aunes-Jansson, Maria

AU - Wahlander, Karin

PY - 2009

Y1 - 2009

M3 - Published meeting abstract

SN - 1524-4539

VL - 120

SP - S1129-S1129

JO - Circulation

JF - Circulation

IS - 18

T2 - 82nd Scientific Session of the American-Heart-Association

Y2 - 14 November 2009 through 18 November 2009

ER -